Michael Connor, MD
Gastroenterology · Kansas City, MONPI 1114924578
Payments from drug & device makers
Across 596 payments — averaging $279.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$154K
- Genentech, Inc.$6K
- Roche Products Limited$2K
- AbbVie$1K
- Johnson & Johnson$561
- Bristol Myers Squibb$376
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,93798%
- Education$1002%
- Entertainment$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 362 | $154,261 |
| Genentech, Inc. | 7 | $6,179 |
| Roche Products Limited | 1 | $1,802 |
| AbbVie | 87 | $1,422 |
| Johnson & Johnson | 24 | $561 |
| Bristol Myers Squibb | 23 | $376 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $297 |
| Pfizer | 16 | $283 |
| Lilly USA, LLC | 8 | $222 |
| Janssen Scientific Affairs, LLC | 2 | $212 |
| Sanofi | 4 | $134 |
| Braintree Laboratories, Inc. | 6 | $90 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| Madrigal Pharmaceuticals | 3 | $69 |
| Aimmune Therapeutics, Inc. | 4 | $68 |
| Celltrion USA Inc. | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Intercept Pharmaceuticals, Inc. | 3 | $54 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Amgen | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Ardelyx, Inc. | 2 | $33 |
| Boston Scientific | 2 | $29 |
| QOL Medical, LLC | 1 | $29 |
| Romark Laboratories, LC | 1 | $25 |
| Organon | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Mauna Kea Technologies, Inc. | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Merck | 1 | $13 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$166,594 in reported general payments places this provider in the 90th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 11 | $271,888 |
| Skyrizi On-BodyRisankizumab-Rzaa | 13 | $259,308 |
| OcalivaObeticholic Acid | 14 | $132,452 |
| RinvoqUpadacitinib | 13 | $82,265 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 95 | $13,565 |
| LinzessLinaclotide | 20 | $11,313 |
| Mesalamine | 21 | $8,251 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 44 | $7,320 |
| Omeprazole | 262 | $3,082 |
| Budesonide EcBudesonide | 18 | $2,816 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 17 | $2,116 |
| Balsalazide Disodium | 13 | $1,551 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 90 | $1,466 |
| Budesonide DrBudesonide | 11 | $1,380 |
| Dicyclomine Hcl | 17 | $661 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $561 | $271,88811 claims |
| Intercept Pharmaceuticals, Inc.Ocaliva | $54 | $132,45214 claims |
| AbbVieRinvoq, Linzess | $1,422 | $93,57833 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu | $297 | $13,56595 claims |
| Braintree Laboratories, Inc.Sutab, Suflave | $90 | $9,43661 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 374 gastroenterology providers in Missouri.
Other gastroenterology in Kansas City
- Bradley FreilichKansas City$4.5M
- Amit RastogiKansas City$453K
- Hillary BownikKansas City$414K
- Prashant PandyaKansas City$286K
- Laith Al MomaniKansas City$276K
- Ahmed SaeedKansas City$246K
- Tahar MahmoudiKansas City$114K
- Rajiv ChhabraKansas City$100K
- Paresh PatelKansas City$55K
- Parakkal DeepakSaint Louis$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.